Compare Organon Pharma Indonesia Tbk. (SCPI) vs Sriwahana Adityakarta Tbk. (SWAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Sriwahana Adityakarta Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Sriwahana Adityakarta Tbk. trades at Rp16 (market cap 48.31B). The key difference: Organon Pharma Indonesia Tbk. is far larger — about 2.2× Sriwahana Adityakarta Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SWAT | |
|---|---|---|
Market Cap | 104.4B | 48.31B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Sriwahana Adityakarta Tbk.
PT Sriwahana Adityakarta (the Company) was established on July 2, 1990 by Notarial DeedNo. 1 of Ruth Karliena, S.H., notary in Surakarta.
Read more on SWAT →
